Argitalpenak (100) MERCEDES ALPERI LOPEZ argitalpenak

filter_list

2025

  1. Decreased GPR55 expression links B-cell activation and vascular remodelling in atherosclerosis in patients with early rheumatoid arthritis

    RMD Open, Vol. 11, Núm. 3

  2. Golimumab retention in patients with psoriatic arthritis and axial spondyloarthritis: evidence from up to a decade of follow-up

    Expert Review of Clinical Pharmacology, Vol. 18, Núm. 5, pp. 313-322

  3. Higher frequencies of age-associated B-cells in early arthritis are linked to atherosclerosis and immune circuits - A potential role as a biomarker for risk stratification

    Rheumatology, Vol. 64, Núm. 11, pp. 5921-5931

  4. Precision medicine in rheumatoid arthritis: Evaluation of a new approach to predict clinical response to methotrexate in patients with early rheumatoid arthritis

    PLOS ONE, Vol. 20, Núm. 8 August

  5. Psoriatic arthritis phenotype may vary depending on whether the skin or joint domain appears first or whether both appear simultaneously

    Clinical and experimental rheumatology, Vol. 43, Núm. 5, pp. 889-896

  6. Reassessing traditional inflammatory biomarkers in spondyloarthritis: time for a paradigm shift?

    Expert Review of Clinical Immunology

  7. Study of the impact of the inclusion of global pain and functional capacity assessment in the definition of remission and its maintenance for rheumatoid arthritis. Aims and methodology

    Reumatologia Clinica, Vol. 21, Núm. 5

  8. Tailoring Inflammatory Biomarker Assessment in Axial Spondyloarthritis: A Comparative Study of Erythrocyte Sedimentation Rate and C-Reactive Protein Across Disease Profiles

    Journal of Personalized Medicine, Vol. 15, Núm. 8

2024

  1. Do the Activity Indices Used in Axial Spondyloarthritis Capture the Relationships Between Obesity, Smoking and Disease Activity in the Same Way?

    Journal of Clinical Medicine, Vol. 13, Núm. 22

  2. Searching for a Novel HLA-Cw6-Linked Cardiometabolic Endotype in Psoriatic Disease

    Biomedicines, Vol. 12, Núm. 10

  3. Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes

    Genome Biology, Vol. 25, Núm. 1

2023

  1. Acroosteolysis and facial dysmorphia: a new case of Hajdu-Cheney Syndrome

    Reumatologia Clinica, Vol. 19, Núm. 9, pp. 527-529

  2. Are Patients with Axial Spondyloarthritis Who Were Breastfed Protected against the Development of Severe Disease?

    Journal of Clinical Medicine, Vol. 12, Núm. 5

  3. Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages

    Rheumatology (Oxford, England), Vol. 62, Núm. 8, pp. 2898-2907

  4. Managing psoriatic arthritis in different clinical scenarios

    Expert Review of Clinical Immunology, Vol. 19, Núm. 12, pp. 1469-1484

  5. Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience

    Journal of Clinical Medicine, Vol. 12, Núm. 2

2022

  1. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis

    Reumatologia Clinica, Vol. 18, Núm. 1, pp. 33-41

  2. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

    eBioMedicine, Vol. 80

  3. Non-Physical Disease Facets in Spondyloarthritis: An ASAS Health Index-Based Analysis between Psoriatic Arthritis and Axial Spondyloarthritis

    Journal of Clinical Medicine, Vol. 11, Núm. 20

  4. The ASAS Health Index: A New Era for Health Impact Assessment in Spondyloarthritis

    The Journal of rheumatology, Vol. 49, Núm. 1, pp. 8-15